May 17, 2020

FDA Supply Chain Chief Says Cancer, Not Can'tcer

FDA
cancer drugs
Supply Chain
Efficiency
Freddie Pierce
2 min
One makes you smaller, one makes you have less cancer
The U.S. Food and Drug Administration has announced that it will address emergency shortages of cancer drugs with superior logistics. “A drug sho...

The U.S. Food and Drug Administration has announced that it will address emergency shortages of cancer drugs with superior logistics.

“A drug shortage can be a frightening prospect for patients and President Obama made it clear that preventing these shortages from happening is a top priority of his administration," said FDA Commissioner Margaret A. Hamburg, M.D.. “Through the collaborative work of FDA, industry, and other stakeholders, patients and families waiting for these products or anxious about their availability should now be able to get the medication they need.”

Essentially, this will mean the emergency importation of compatible cancer drugs that have not yet been approved by the FDA.  The supply chain will be strengthened at the expense of scientific and bureaucratic imperative. 

SEE RELATED STORIES FROM THE WDM CONTENT NETWORK:

·         Apple supply chain under fire from Change.org protest

·         Homeland Security announces supply chain crisis plan

Click here to read the latest edition of Supply Chain Digital

It’s an emergency measure meant to address recent shortages in life-saving cancer drugs, with some patients of ovarian and other cancers going a month without medication.  Since demand for approved domestic brands outstrips supply, the FDA is ostensibly making a muscular gesture to enforce patient safety at all costs.

Those costs, some Cassandras warn, may be that very safety.  But the FDA is standing firmly behind its decision.

“The actions announced today will help to boost the supply of some of the most badly needed cancer drugs by patients across the country,” Dr. J. Leonard Lichtenfeld, deputy chief medical officer of the American Cancer Society stated, according to the media outlet. “It is critical that the FDA ensure that the added supply of these drugs is safe and made easily available to the patients who urgently need them.”

Click here to download Supply Chain Digital’s iPad app!

Share article

Jun 16, 2021

EU and US agree end to Airbus-Boeing supply chain tariffs

supplychain
Boeing
Airbus
tariffs
3 min
Supply chains embroiled in Airbus-Boeing dispute will no longer be impacted by $11.5bn tariffs imposed on food and beverage, aircraft and tobacco

The EU and US have agreed to resolve a 17-year dispute over aircraft subsidies, suspending tariffs on billions of dollars' worth of goods that have plagued procurement leaders on both sides of the Atlantic. 

Under an agreement reached by European Commission Executive Vice-President Valdis Dombrovskis and US Trade Representative Katherine Tai on Tuesday, the tariffs will be halted for a period of at least five years. 

It will bring an end to punitive and disruptive levies on supply chains that have little to do with the argument, which became embroiled in the trade battle. Businesses on both sides of the dispute have been hit with more than $3.3bn in duties since they were first imposed by the US in October 2019, according the EC. 

The US imposed charges on goods upto $7.5bn in response to a World Trade Organisation ruling that judged the EU’s support of Airbus, its biggest aircraft manufacturer, unlawful. A year later in November 2020, the EU hit back. The WTO found the US had violated trade rules in its favourable treatment of Boeing, and was hit with EU duties worth $4bn. 

In all the tariffs affected $11.5bn worth of goods, including French cheese, Scotch whisky, aircraft and machinery in Europe, and sugarcane products, handbags and tobacco in America. Procurement leaders on both sides of the fence were forced to wrestle with tariffs of 15% on aircraft and components, and 25% on non-aircraft related products. 

Boeing-Airbus dispute by the numbers  

  • The dispute began in 2004
  • Tariffs suspended for 5 years 
  • $11.5bn worth of goods affected by tariffs
  • $3.3bn in duties paid by businesses to date 
  • 15% levy on aircraft and 25% on non-aircraft goods suspended

Both sides welcome end to tariffs 

European Commission President Ursula von der Leyen branded the truce a “major step” in ending what is the longest running dispute in WTO history. It began in 2004.

“I am happy to see that after intensive work between the European Commission and the US administration, our transatlantic partnership is on its way to reaching cruising speed. This shows the new spirit of cooperation between the EU and the US and that we can solve the other issues to our mutual benefit,” she added.

Both aircraft manufacturers have welcomed the news. Airbus said in a statement that it will hopefully bring to an end the “lose-lose tariffs” that are affecting industries already facing “many challenges”. Boeing added that it will “fully support the U.S. Government’s efforts to ensure that the principles in this understanding are respected”. 

The US aerospace firm added: "The understanding reached today commits the EU to addressing launch aid, and leaves in place the necessary rules to ensure that the EU and United States live up to that commitment, without requiring further WTO action."

This week’s decision expands upon a short-term tariff truce announced in March this year. The EC says it will work closely with the US to try and further resolve the dispute, establishing a Working Group on Large Civil Aircraft led by each side’s trade minister.

Airbus last month signalled to suppliers that post-pandemic recovery was on the horizon, telling them to scale up to meet a return to pre-COVID manufacturing levels. “The aviation sector is beginning to recover from the COVID-19 crisis,” said Airbus chief executive Guillaume Faury, adding that suppliers should prepare for a period of intensive production “when market conditions call for it.”

Share article